These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8022074)

  • 1. [Detection of antinuclear antibodies and their significance as disease markers].
    Yoshida H; Imafuku Y; Morita EO; Nagai T; Kato Y; Motegi S
    Rinsho Byori; 1994 May; 42(5):455-9. PubMed ID: 8022074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-nuclear antibodies (ANA) in sera of aged subjects, with special reference to two cases with high titers of anti-centromere antibody (ACA)].
    Moteki S; Yoshida H; Watanabe N; Sato K; Saito M
    Rinsho Byori; 1991 Mar; 39(3):273-7. PubMed ID: 2051602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoserological area--with special reference to the current topics on antinuclear antibodies].
    Moteki S; Yoshida H
    Rinsho Byori; 1990 Jul; 38(7):765-72. PubMed ID: 2205741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of autoantibodies coexisting with anti-centromere antibodies in sera of patients with primary biliary cirrhosis].
    Moteki S; Yoshida H; Nishimaki T; Morito T
    Rinsho Byori; 1990 Aug; 38(8):888-94. PubMed ID: 2232249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of enzyme-linked immunosorbent assay for antinuclear antibodies].
    Nakabayashi T; Kumagai T; Sakagami S; Furihata K; Katuyama T
    Rinsho Byori; 1998 Sep; 46(9):942-7. PubMed ID: 9800481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis.
    Remmel T; Piirsoo A; Koiveer A; Remmel H; Uibo R; Salupere V
    Hepatogastroenterology; 1996; 43(11):1135-40. PubMed ID: 8908541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients.
    Ruffatti A; Artifoni L; Glorioso S; Calligaro A; Doria A; Gambari P; Todesco S
    J Rheumatol; 1985 Oct; 12(5):940-3. PubMed ID: 3878881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of anticytoplasmic antibodies found on fluorescent antinuclear antibody testing.
    Tesser JR; Rothberger H; Agudelo C
    J Rheumatol; 1983 Apr; 10(2):227-34. PubMed ID: 6345769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinuclear antibody screening by an enzyme-linked immunosorbent assay using multiple nuclear antigens].
    Iwata H; Aotsuka S; Okawa M; Kinoshita M; Sumiya M
    Ryumachi; 1997 Aug; 37(4):548-55. PubMed ID: 9311280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in clinical tests and the pathophysiological study of collagen diseases--anti-topoisomerase I antibodies and anticentromere antibodies].
    Konndo H
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2409-13. PubMed ID: 9922659
    [No Abstract]   [Full Text] [Related]  

  • 20. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.